Recurrence of Helicobacter Pylori after Successful Eradication in Northwestern China: Rates, Risk Factors, and Resistance Profiles of Recurrence Isolates.
- 1Gastroenterology Department, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, People's Republic of China.
- 2Gastroenterology Department, The Fifth People's Hospital of Ningxia Hui Autonomous Region, Shizuishan, Ningxia, People's Republic of China.
Abstract
Purpose
This study aimed to investigate the recurrence rate of H. pylori after successful eradication in Ningxia, to identify independent risk factors associated with recurrence, and to characterize the antibiotic resistance profiles of isolates obtained from recurrent patients.Methods
This study is a retrospective cohort study. A total of 891 H. pylori-infected patients who received initial eradication treatment and completed 1-year follow-up from June 2021 to October 2024 were included. Demographic characteristics, lifestyle, family hygiene habits, and antibiotic exposure history were collected through questionnaires. A total of 27 strains successfully isolated and cultured from patients with recurrence were tested for antibiotic susceptibility using the Kirby-Bauer disk diffusion method.Results
The H. pylori recurrence rate was 4.1% (37/891). Multivariate logistic regression identified six independent risk factors: rural residence (OR = 3.52, P = 0.003), smoking (OR = 6.06, P < 0.001), frequent shared tableware (OR = 3.46, P = 0.013), frequent dining out (OR = 7.41, P = 0.008), poor dining-out hygiene (OR = 4.50, P = 0.007), and having an H. pylori-infected household member (OR = 5.68, P < 0.001). Of the 37 patients with recurrence, 27 had successful H. pylori culture and obtained susceptibility results. The resistance rates to metronidazole (MET), clarithromycin (CLA), levofloxacin (LEV), and amoxicillin (AMO) were 96.3%, 77.8%, 62.9%, and 3.7%, respectively; all isolates were susceptible to furazolidone (FUR) and tetracycline (TET). Multidrug-resistance was observed in 51.8%, mainly as MET+CLA+LEV pattern (48.1%).Conclusion
The one-year recurrence rate of H. pylori in Ningxia is 4.1%. Factors significantly associated with an increased risk of recurrence include rural residence, smoking, shared tableware, regular dining out, poor dining-out hygiene, and household infection. Isolates from patients with recurrence exhibited high resistance rates to MET, CLA, and LEV, predominantly in multidrug-resistant patterns, whereas resistance to AMO, FUR, and TET remains low.
Related
- Incidentally Detected Persistent Helicobacter heilmannii Gastritis in a Korean Woman With a Normal Endoscopic Examination: Successful Eradication After Salvage Therapy
- Antimicrobial Resistance-Stratified Efficacy of Vonoprazan, Clarithromycin, and Metronidazole Therapy for Helicobacter pylori Eradication in Penicillin-Allergic Patients: A Single-Arm Prospective Interventional Study.
- Helicobacter pylori Infection in Rome IV Functional Dyspepsia: Association with the Epigastric Pain Syndrome Phenotype and Long-Term Response to Eradication
- Efficacy and Safety of Tegoprazan–Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis of Randomized Controlled Trials
- Gastric Cancer: Global Epidemiology, Risk Factors, Helicobacter pylori Eradication, and Risk-Based Screening
BibTeX
@article{niu2026recurrence,
title = {{Recurrence of Helicobacter Pylori after Successful Eradication in Northwestern China: Rates, Risk Factors, and Resistance Profiles of Recurrence Isolates.}},
author = {Min Niu and Xiaoming Su and Zhen Ma and Lulu Li},
journal = {Infection and drug resistance},
year = {2026},
month = oct,
doi = {10.2147/idr.s636223},
url = {https://europepmc.org/article/MED/42898539},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Recurrence of Helicobacter Pylori after Successful Eradication in Northwestern China: Rates, Risk Factors, and Resistance Profiles of Recurrence Isolates.
AU - Min Niu
AU - Xiaoming Su
AU - Zhen Ma
AU - Lulu Li
PY - 2026
DA - 2026/10/13
JO - Infection and drug resistance
DO - 10.2147/idr.s636223
UR - https://europepmc.org/article/MED/42898539
AB - Purpose This study aimed to investigate the recurrence rate of H. pylori after successful eradication in Ningxia, to identify independent risk factors associated with recurrence, and to characterize the antibiotic resistance profiles of isolates obtained from recurrent patients.Methods This study is a retrospective cohort study. A total of 891 H. pylori-infected patients who received initial eradication treatment and completed 1-year follow-up from June 2021 to October 2024 were included. Demographic characteristics, lifestyle, family hygiene habits, and antibiotic exposure history were collected through questionnaires. A total of 27 strains successfully isolated and cultured from patients with recurrence were tested for antibiotic susceptibility using the Kirby-Bauer disk diffusion method.Results The H. pylori recurrence rate was 4.1% (37/891). Multivariate logistic regression identified six independent risk factors: rural residence (OR = 3.52, P = 0.003), smoking (OR = 6.06, P < 0.001), frequent shared tableware (OR = 3.46, P = 0.013), frequent dining out (OR = 7.41, P = 0.008), poor dining-out hygiene (OR = 4.50, P = 0.007), and having an H. pylori-infected household member (OR = 5.68, P < 0.001). Of the 37 patients with recurrence, 27 had successful H. pylori culture and obtained susceptibility results. The resistance rates to metronidazole (MET), clarithromycin (CLA), levofloxacin (LEV), and amoxicillin (AMO) were 96.3%, 77.8%, 62.9%, and 3.7%, respectively; all isolates were susceptible to furazolidone (FUR) and tetracycline (TET). Multidrug-resistance was observed in 51.8%, mainly as MET+CLA+LEV pattern (48.1%).Conclusion The one-year recurrence rate of H. pylori in Ningxia is 4.1%. Factors significantly associated with an increased risk of recurrence include rural residence, smoking, shared tableware, regular dining out, poor dining-out hygiene, and household infection. Isolates from patients with recurrence exhibited high resistance rates to MET, CLA, and LEV, predominantly in multidrug-resistant patterns, whereas resistance to AMO, FUR, and TET remains low.
SN - 1178-6973
ER -